Matias S. Mendeville

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma.

Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma.

Journal: Nature communications

Published: July 22, 2024

Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.

Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: July 17, 2023

Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma.

Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma.

Journal: Blood advances

Published: July 22, 2022

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.

Journal: Blood advances

Published: June 24, 2022

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice.

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice.

Journal: Frontiers in oncology

Published: June 15, 2022

A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma.

A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma.

Journal: Leukemia

Published: March 27, 2022

Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma.

Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma.

Journal: Cancers

Published: December 28, 2021

Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.

Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.

Journal: Blood

Published: February 14, 2020

Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma.

Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma.

Journal: Blood

Published: December 05, 2018

ACE: absolute copy number estimation from low-coverage whole-genome sequencing data.

ACE: absolute copy number estimation from low-coverage whole-genome sequencing data.

Journal: Bioinformatics (Oxford, England)

Published: July 07, 2018

Benign and malignant tumors in Rubinstein-Taybi syndrome.

Benign and malignant tumors in Rubinstein-Taybi syndrome.

Journal: American journal of medical genetics. Part A

Published: September 27, 2017

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.

Journal: Haematologica

Published: January 31, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026